Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Gelatinase inhibitors developed at Sankyo useful for cancer

July 20, 1998

Selective COX-1 and COX-2 blockade as novel anticancer approach

July 20, 1998

Onconase clinical program update

July 17, 1998

Canadian researchers discover potent new taxane

July 17, 1998

Modulators of MDR described by Xenova

July 17, 1998

Study reports efficacy without side effects of new antitumor antibiotic FK-317

July 17, 1998

TAC-101 potently inhibits liver metastasis and prolongs survival in animal models

July 17, 1998

SU-101 enters phase II testing in ovarian cancer patients

July 16, 1998

More telomerase inhibitors added to the Geron pipeline

July 16, 1998

LG-120907, a potent antiandrogen with reduced adverse effects

July 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...